LTD Tbilisi Oncology Dispensary

Tbilisi 0159

0 studies enrolling now · 1 studies all time

What they study most

Chemotherapy-induced Nausea and Vomiting

Studies at this site

• A Study to Assess the Safety and the Efficacy of IV Fosnetupitant/Palonosetron (260 mg/0.25 mg) Combination Compared to Oral Netupitant/Palonosetron (300 mg/0.5 mg) Combination for the Prevention of CINV in AC Chemotherapy in Women With Breast Cancer — Completed